This Pot Stock Soared 4% After Reporting a Strong Rise in Sales

The Green Organic Dutchman’s (TSX:TGOD) Q4 and year-end 2020 fiscal results showed a strong rise in sales. This pot stock still has lots of upside.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The Green Organic Dutchman (TSX:TGOD), a producer of premium certified organically grown cannabis, released its fourth-quarter and year-end 2020 fiscal results on March 9 after the closing bell. The pot stock soared by 4% shortly after the opening bell on March 10, as the company reported a strong rise in sales.

Sales in Canada were very strong

TGOD reported revenue of $10.92 million in the fourth quarter of 2020. This represents an increase of 236% and 91%, year over year and quarter over quarter, respectively. Canadian cannabis revenue amounted to $8.55 million for the quarter — an increase of 122% from the previous quarter.

TGOD saw increased sales in Canada across all product lines, supported by a strong increase in production at the company’s Ancaster and Valleyfield facilities.

Full-year revenue was $24.51 million — a 120% year-over-year increase.

The company announced that its board of directors has appointed Sean Bovingdon as CEO and board member, effective immediately. Mr Bovingdon had previously been appointed interim CEO in November 2020 while continuing to serve as CFO. He will remain interim CFO while the company undertakes the search for a permanent CFO.

Sean Bovingdon said in a statement, “We delivered strong growth in 2020 thanks to the expansion of our product assortment, including the launch of Highly Dutch, and continuous improvements to our supply chain. This accomplishment, realized against a challenging backdrop, reflects the quality of our products, underpinned by our talented and committed team.”

TGOD charts the course for future growth

Bovingdon also said that the company remains focused on operational execution, as it charts the course for future growth, including opportunities in Europe, Mexico, and the United States.

He noted that several retailers were unable to remain fully open, particularly during Q1 2021, and so we can expect a delay in the growth rate at least until Q2 2021. Bovingdon added that TGOD’s recent Organic Sugar Bush, a high-THC Sativa variety, reflecting the improvements in quality and potency the company has achieved, and the new SKU Hash should give the sales mix an extra boost in the coming months.

TGOD continued to benefit from its cost control programs through further reductions in general and administrative expenses, which were 59% lower compared to the same period in 2019.

The company recorded a net loss of $23.68 million for the quarter compared to $144.75 million for the same period last year, mainly comprised of operating loss and a writedown of $8.65 million of goodwill related to HemPoland.

On November 24, 2020, TGOD announced that it had received an Export Certificate from Health Canada. This certificate allowed the company to complete its first shipment of medical cannabis to Germany, where it is undergoing stability testing, the last step before the company can begin commercialization in 2021. The company expects that once completed, it will also be able to ship to Australia and Mexico, where regulations permit.

In February, TGOD signed a supply agreement with CannMart, a subsidiary of Namaste Technologies, making its certified organic medical cannabis products available through CannMart’s online medical cannabis sales platform. As part of the company’s two-year term agreement with CannMart, the company will provide CannMart with a broad portfolio of certified organic medical cannabis products, including premium dried flowers, RIPPLE soluble powder, gummy candies, and teas.

For fiscal 2021, analysts expect on average a revenue growth of 156% and a profit growth of 96%.

A promising pot stock trading at a discount

TGOD stock hit a 52-week high of $0.65 on February 10, but it fell afterward below $0.40. This is a good opportunity to buy a promising pot stock for a cheap price. Canopy Growth and Village Farms International are two other top pot stocks you might want to have a look at.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Village Farms International Inc. The Motley Fool recommends Namaste Technologies.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »